HER2 Amplification Level Predicts Pathological Complete Response in the Neoadjuvant Setting of HER2-Overexpressing Breast Cancer: A Meta-Analysis and Systematic Review

Anti-HER2 therapies have dramatically improved the prognosis of human epidermal growth factor receptor 2 (HER2)-overexpressing cancers. However, the correlation between the HER2 copy number and the response rate to anti-HER2 remains unclear. Here, following the PRISMA method, we performed a meta-ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonullu, Burak, Angeli, Eurydice, Pamoukdjian, Frédéric, Bousquet, Guilhem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960382/
https://www.ncbi.nlm.nih.gov/pubmed/36834998
http://dx.doi.org/10.3390/ijms24043590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960382/
https://www.ncbi.nlm.nih.gov/pubmed/36834998
http://dx.doi.org/10.3390/ijms24043590

Ejemplares similares